10.18
-1.74%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Huakang Pharmaceutical Co
Its shares trade on Shanghai under the ticker 605077.SS. It has been listed since 9 February 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥4.19bn and net income of CN¥200.3m. At that date it held total assets of CN¥8.04bn and shareholders' equity of CN¥3.24bn.
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of functional sugar alcohols and starch sugar products. The company is headquartered in Quzhou, Zhejiang. The company went IPO on 2021-02-09. The firm's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The firm conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 9 Feb 2021
- Employees
- 1,350
- Website
- huakangpharma.com ↗
Leadership
Pay as last reported
- Mr. Deshui ChenChairman of the Board, General Manager, since 2020CN¥1.5m
- Mr. Jianming YuVice Chairman of the Board, since 2020CN¥1.2m
- Mr. Jiafa WangFinance Director
- Mr. Xinping ChengExecutive Deputy General Manager, Director, since 2020CN¥1.3m
- Mr. Xiaoyang ZhengDeputy General Manager, Director, since 2023
- Mr. Zhiping WuSecretary of the Board
- Mr. Yongrui DuDirectorCN¥1.2m
- Mr. Xiaorong XuDirectorCN¥99,400
- Ms. Fengqin FengIndependent DirectorCN¥72,000
- Mr. Junfeng GuoIndependent DirectorCN¥72,000
- Mr. Jun LiIndependent Director
- Mr. Jianmiao XuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Huakang Pharmaceutical's xylitol and sorbitol are key products in China's food sector.
- The company's maltitol and grape syrup are widely used in beverage and daily chemical industries.
- Quzhou-based production supports efficient supply chain within China's Consumer Staples market.
Weaknesses
- Limited overseas market presence beyond Europe, America, and Asia regions.
- Dependence on China's domestic market for significant revenue generation.
- No mention of product diversification beyond sugar alcohols and starch sugars.
Opportunities
- Expanding into new markets in Europe and America for functional sugar alcohols.
- Growing demand for natural sweeteners in the global food industry.
- Increasing international trade opportunities in the Consumer Staples sector.
Threats
- Competition from established players in China's food product market.
- Regulatory changes affecting sugar alcohol usage in food and beverages.
- Economic downturns impacting consumer spending on discretionary food items.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.